Richard Chesworth - 17 Aug 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role: Chief Scientific Officer
Signature: /s/ Bruce Jacobs, as Attorney-in-Fact
Issuer symbol: KYMR
Transactions as of: 17 Aug 2021
Net transactions value: -$1,640,182
Form type: 4
Filing time: 19 Aug 2021, 16:30:31 UTC
Next filing: 27 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KYMR	Common Stock	Options Exercise	$1,080,000	+54,000		$20.00	54,000	17 Aug 2021	Direct
transaction	KYMR	Common Stock	Sale	$439,612	-8,809	-16%	$49.90	45,191	17 Aug 2021	Direct	F1, F2
transaction	KYMR	Common Stock	Sale	$2,114,243	-41,975	-93%	$50.37	3,216	17 Aug 2021	Direct	F1, F3
transaction	KYMR	Common Stock	Sale	$151,325	-2,928	-91%	$51.68	288	17 Aug 2021	Direct	F1, F4
transaction	KYMR	Common Stock	Sale	$15,002	-288	-100%	$52.09	0	17 Aug 2021	Direct	F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYMR	Stock Option (Right to Buy)	Options Exercise	$0	-54,000	-15%	$0.000000	297,119	17 Aug 2021	Common Stock	54,000	$20.00	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
F2	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.04 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.04 to $51.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.05 to $52.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.06 to $52.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6	Twenty-five percent (25%) of the shares subject to this option vested and became exercisable on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter.